I+Med layes the foundation stone of what will be its headquarters: the first International Biomedical Institute for Smart Nanohydrogels

i+Med invests 20 million euros and promotes the world's first Biomedical Institute for Intelligent Nanohydrogels [Press release]

i+Med introduces BuddyDrops®, the only sustained-release ectoin eye drops for pets

i+Med presenta BuddyDrops®, las únicas gotas oftálmicas para mascotas con ectoína y de liberación sostenida

Presentamos Adaptek Technology

DayDrop, gota oftálmica con liberación controlada de ectoína

Obtención del Marcado CE para OpHLINE y TrHLINE